{
    "ticker": "BSCP",
    "name": "BioSig Technologies, Inc.",
    "description": "BioSig Technologies, Inc. is a medical technology company focused on developing innovative solutions for the electrophysiology market. Founded in 2010 and based in Westport, Connecticut, BioSig aims to enhance the quality and efficacy of cardiac procedures through its proprietary technology platform. The company\u2019s flagship product, the PURE EP System, is designed to provide advanced signal processing capabilities for electrophysiologists, enabling them to achieve greater precision in diagnosing and treating cardiac arrhythmias. BioSig's technology allows for the real-time visualization of cardiac signals, helping clinicians make more informed decisions during procedures. The company's mission is to improve patient outcomes and optimize procedural efficiencies in the field of electrophysiology. In addition to the PURE EP System, BioSig is actively engaged in research and development to expand its product offerings and further advance its technological capabilities. By collaborating with leading academic institutions and healthcare professionals, BioSig is committed to addressing the unmet needs in cardiac care and enhancing the overall experience for both patients and healthcare providers. As the demand for innovative medical technologies continues to grow, BioSig stands at the forefront of transforming the landscape of cardiac diagnostics and treatment.",
    "industry": [
        "Medical Technology",
        "Healthcare"
    ],
    "headquarters": "Westport, Connecticut, USA",
    "founded": "2010",
    "website": "https://www.biosig.com",
    "ceo": "W. Scott Bice",
    "social_media": {
        "twitter": "https://twitter.com/BioSigTech",
        "linkedin": "https://www.linkedin.com/company/biosig-technologies-inc-"
    },
    "investor_relations": "https://www.biosig.com/investor-relations",
    "key_executives": [
        {
            "name": "W. Scott Bice",
            "position": "CEO"
        },
        {
            "name": "David M. Drachman",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Electrophysiology Devices",
            "products": [
                "PURE EP System"
            ]
        }
    ],
    "seo": {
        "meta_title": "BioSig Technologies, Inc. | Innovative Electrophysiology Solutions",
        "meta_description": "Explore BioSig Technologies, Inc., a leader in medical technology focused on improving cardiac care through innovative electrophysiology solutions.",
        "keywords": [
            "BioSig",
            "Electrophysiology",
            "Cardiac Care",
            "Medical Technology",
            "PURE EP System"
        ]
    },
    "faq": [
        {
            "question": "What is BioSig Technologies known for?",
            "answer": "BioSig Technologies is known for developing innovative medical devices for the electrophysiology market."
        },
        {
            "question": "Who is the CEO of BioSig Technologies?",
            "answer": "W. Scott Bice is the CEO of BioSig Technologies, Inc."
        },
        {
            "question": "Where is BioSig headquartered?",
            "answer": "BioSig is headquartered in Westport, Connecticut, USA."
        },
        {
            "question": "What is the main product of BioSig Technologies?",
            "answer": "The main product is the PURE EP System, which enhances cardiac signal visualization during procedures."
        },
        {
            "question": "When was BioSig Technologies founded?",
            "answer": "BioSig Technologies was founded in 2010."
        }
    ],
    "competitors": [
        "MDT",
        "ABT",
        "RMD"
    ],
    "related_stocks": [
        "JNJ",
        "ISRG",
        "SYK",
        "BSX"
    ]
}